Trius Therapeutics, Inc. (TSRX)

[north40000]

When BMY announced its TO for MEDX @ 16/share a few years back,the original expiration period was extended some days, and finally BMY got the necessary 90% of shares for a so-called short form merger. A few of us did not tender our shares by the new expiration date. A very few days after TO expiration, our shares disappeared from our accounts to be replaced by $16/share.